HCA Healthcare (HCA) Q4 2025 (USD): EPS 8.14 (exp. 7.45), Revenue 19.5bln (exp. 19.67bln); sees FY revenue at 76.5- 80bln (exp. 79.02bln); to buy back shares of up to USD 10bln

HCA Healthcare delivered a strong earnings per share (EPS) beat which may bolster investor confidence despite a slight miss on revenue expectations.

Newsquawk StaffPublished On the live feed at 2 more headlines followed before this page went public
Newsquawk headlinesUTC

US BROKER MOVES: CRWV upgraded at Deutsche Bank; AA downgraded at Morgan Stanley

Ukraine's Naftogaz says Russia attacked its facility in western Ukraine

HCA Healthcare (HCA) Q4 2025 (USD): EPS 8.14 (exp. 7.45), Revenue 19.5bln (exp. 19.67bln); sees FY revenue at 76.5- 80bln (exp. 79.02bln); to buy back shares of up to USD 10bln

EU Commission still expects to propose Russia oil ban by the end of the year; does not have any timeline for Russia nuclear ban

China's Vanke wins creditor approval to extend another two CNY bonds

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

The company's share buyback announcement of up to $10 billion signals robust cash flow and a commitment to returning value to shareholders. However, the full-year revenue guidance appears conservative relative to market expectations, which can introduce some caution among investors.

Related headlines

The whole workspace, free to try.

Try it free